0001209191-23-038443.txt : 20230620
0001209191-23-038443.hdr.sgml : 20230620
20230620164809
ACCESSION NUMBER: 0001209191-23-038443
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pellizzari Christine A
CENTRAL INDEX KEY: 0001127430
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 231025907
MAIL ADDRESS:
STREET 1: 10 FINDERNE AVENUE
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER NAME:
FORMER CONFORMED NAME: PELLIZZARI CHRISTINE A
DATE OF NAME CHANGE: 20001030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tempest Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-798-8589
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Millendo Therapeutics, Inc.
DATE OF NAME CHANGE: 20181207
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-15
0
0001544227
Tempest Therapeutics, Inc.
TPST
0001127430
Pellizzari Christine A
C/O TEMPEST THEARAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
1
0
0
0
0
Stock Option (right to buy)
1.42
2023-06-15
4
A
0
8200
0.00
A
2033-06-14
Common Stock
8200
8200
D
The shares underlying the option will vest in full on the earlier of (i) June 15, 2024, or (ii) the day of the Issuer's 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.
/s/ Stephen Brady, Attorney-in-Fact for Christine Pellizzari
2023-06-20